RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"
RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"
redhill biopharma已获得17/900,235号美国专利申请的通知书，题为“冠状病毒肺炎生物标志物（用于治疗冠状病毒感染或预防由冠状病毒感染引起的疾病）”。
RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"
redhill biopharma已获得17/900,235号美国专利申请的通知书，题为“冠状病毒肺炎生物标志物（用于治疗冠状病毒感染或预防由冠状病毒感染引起的疾病）”。
资讯热榜
更新时间